RNF151
RING finger protein 151
Also known as: RN151_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q2KHN1
- Gene
- RNF151
- Ensembl
- ENSG00000179580
- Chromosome
- 16
- Canonical length
- 245 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Vesicles,Cytosol
OverviewNCBI Gene
Predicted to enable enzyme binding activity; identical protein binding activity; and zinc ion binding activity. Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
245 residues, UniProt reviewed canonical sequence.
>Q2KHN1|RNF151
1 MGGGYDLNLF ASPPDSNFVC SVCHGVLKRP ARLPCSHIFC KKCILRWLAR QKTCPCCRKE
61 VKRKKVVHMN KLRKTIGRLE VKCKNADAGC IVTCPLAHRK GHQDSCPFEL TACPNEGCTS
121 QVPRGTLAEH RQHCQQGSQQ RCPLGCGATL DPAERARHNC YRELHNAWSV RQERRRPLLL
181 SLLRRVRWLD QATSVVRREL AELSNFLEED TALLEGAPQE EAEAAPEGNV GAEVVGEPRA
241 NIPCKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RNF151 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 186 nTPM
Expression across tissuesHPA
Tissue
- testis: 186 nTPM
- breast: 0.1 nTPM
- cerebellum: 0.1 nTPM
- colon: 0.1 nTPM
- kidney: 0.1 nTPM
- liver: 0.1 nTPM
Single-cell type
- early spermatids: 2,667 nCPM
- late spermatids: 1,977 nCPM
- late primary spermatocytes: 333 nCPM
- sertoli cells: 12 nCPM
- leydig cells: 4.6 nCPM
- peritubular myoid cells: 2.4 nCPM
Immune cell
- T-reg: 0.3 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- white matter: 1.3 nTPM
- cerebellum: 1.2 nTPM
- basal ganglia: 1 nTPM
- medulla oblongata: 0.9 nTPM
- pons: 0.9 nTPM
- cerebral cortex: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.65
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.31
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RNF151 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RNF151 as an antibody target. Whether an autoantibody or antibody against RNF151 could matter depends on whether native RNF151 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RNF151 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RNF151 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...